Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc

Bullboard Posts

Post by moneystarvedon Feb 15, 2013 2:47pm

267 Views

Post# 20997289

Good things are coming...

with all the potential news in the pipeline, we will be slow and steady from here on up.

A lot to look forward to this year! My call is this company will be swallowed up by a major by the end of 2013!!

hopefully all of you have been able to get sizeable postiions in the $0.50-$0.70 range. once the news/results start coming, its all goign to look like a bargain.

Good luck (although i believe there is no luck needed for this stock).

MS.

Bullboard Posts

Three micro-cap stocks on an upswing worth riding